A Small Step, a Giant Leap: Somatic Hypermutation of a Single Amino Acid Leads to Anti-La Autoreactivity
The anti-La mab 312B, which was established by hybridoma technology from human-La transgenic mice after adoptive transfer of anti-human La T cells, immunoprecipitates both native eukaryotic human and murine La protein. Therefore, it represents a true anti-La autoantibody. During maturation, the anti...
Guardado en:
Autores principales: | , , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/81bdb80441084ae9a22ff72a15acbb10 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:81bdb80441084ae9a22ff72a15acbb10 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:81bdb80441084ae9a22ff72a15acbb102021-11-11T17:26:32ZA Small Step, a Giant Leap: Somatic Hypermutation of a Single Amino Acid Leads to Anti-La Autoreactivity10.3390/ijms2221120461422-00671661-6596https://doaj.org/article/81bdb80441084ae9a22ff72a15acbb102021-11-01T00:00:00Zhttps://www.mdpi.com/1422-0067/22/21/12046https://doaj.org/toc/1661-6596https://doaj.org/toc/1422-0067The anti-La mab 312B, which was established by hybridoma technology from human-La transgenic mice after adoptive transfer of anti-human La T cells, immunoprecipitates both native eukaryotic human and murine La protein. Therefore, it represents a true anti-La autoantibody. During maturation, the anti-La mab 312B acquired somatic hypermutations (SHMs) which resulted in the replacement of four aa in the complementarity determining regions (CDR) and seven aa in the framework regions. The recombinant derivative of the anti-La mab 312B in which all the SHMs were corrected to the germline sequence failed to recognize the La antigen. We therefore wanted to learn which SHM(s) is (are) responsible for anti-La autoreactivity. Humanization of the 312B ab by grafting its CDR regions to a human Ig backbone confirms that the CDR sequences are mainly responsible for anti-La autoreactivity. Finally, we identified that a single amino acid replacement (D > Y) in the germline sequence of the CDR3 region of the heavy chain of the anti-La mab 312B is sufficient for anti-La autoreactivity.Tabea BartschClaudia ArndtLiliana R. LoureiroAlexandra KeglerEdinson Puentes-CalaJavier Andrés SotoBiji T. KurienAnja FeldmannNicole BerndtMichael P. BachmannMDPI AGarticleanti-La/SS-B antibodiesautoimmunityLa/SS-B autoantigensystemic lupus erythematosusprimary Sjögren’s syndromeBiology (General)QH301-705.5ChemistryQD1-999ENInternational Journal of Molecular Sciences, Vol 22, Iss 12046, p 12046 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
anti-La/SS-B antibodies autoimmunity La/SS-B autoantigen systemic lupus erythematosus primary Sjögren’s syndrome Biology (General) QH301-705.5 Chemistry QD1-999 |
spellingShingle |
anti-La/SS-B antibodies autoimmunity La/SS-B autoantigen systemic lupus erythematosus primary Sjögren’s syndrome Biology (General) QH301-705.5 Chemistry QD1-999 Tabea Bartsch Claudia Arndt Liliana R. Loureiro Alexandra Kegler Edinson Puentes-Cala Javier Andrés Soto Biji T. Kurien Anja Feldmann Nicole Berndt Michael P. Bachmann A Small Step, a Giant Leap: Somatic Hypermutation of a Single Amino Acid Leads to Anti-La Autoreactivity |
description |
The anti-La mab 312B, which was established by hybridoma technology from human-La transgenic mice after adoptive transfer of anti-human La T cells, immunoprecipitates both native eukaryotic human and murine La protein. Therefore, it represents a true anti-La autoantibody. During maturation, the anti-La mab 312B acquired somatic hypermutations (SHMs) which resulted in the replacement of four aa in the complementarity determining regions (CDR) and seven aa in the framework regions. The recombinant derivative of the anti-La mab 312B in which all the SHMs were corrected to the germline sequence failed to recognize the La antigen. We therefore wanted to learn which SHM(s) is (are) responsible for anti-La autoreactivity. Humanization of the 312B ab by grafting its CDR regions to a human Ig backbone confirms that the CDR sequences are mainly responsible for anti-La autoreactivity. Finally, we identified that a single amino acid replacement (D > Y) in the germline sequence of the CDR3 region of the heavy chain of the anti-La mab 312B is sufficient for anti-La autoreactivity. |
format |
article |
author |
Tabea Bartsch Claudia Arndt Liliana R. Loureiro Alexandra Kegler Edinson Puentes-Cala Javier Andrés Soto Biji T. Kurien Anja Feldmann Nicole Berndt Michael P. Bachmann |
author_facet |
Tabea Bartsch Claudia Arndt Liliana R. Loureiro Alexandra Kegler Edinson Puentes-Cala Javier Andrés Soto Biji T. Kurien Anja Feldmann Nicole Berndt Michael P. Bachmann |
author_sort |
Tabea Bartsch |
title |
A Small Step, a Giant Leap: Somatic Hypermutation of a Single Amino Acid Leads to Anti-La Autoreactivity |
title_short |
A Small Step, a Giant Leap: Somatic Hypermutation of a Single Amino Acid Leads to Anti-La Autoreactivity |
title_full |
A Small Step, a Giant Leap: Somatic Hypermutation of a Single Amino Acid Leads to Anti-La Autoreactivity |
title_fullStr |
A Small Step, a Giant Leap: Somatic Hypermutation of a Single Amino Acid Leads to Anti-La Autoreactivity |
title_full_unstemmed |
A Small Step, a Giant Leap: Somatic Hypermutation of a Single Amino Acid Leads to Anti-La Autoreactivity |
title_sort |
small step, a giant leap: somatic hypermutation of a single amino acid leads to anti-la autoreactivity |
publisher |
MDPI AG |
publishDate |
2021 |
url |
https://doaj.org/article/81bdb80441084ae9a22ff72a15acbb10 |
work_keys_str_mv |
AT tabeabartsch asmallstepagiantleapsomatichypermutationofasingleaminoacidleadstoantilaautoreactivity AT claudiaarndt asmallstepagiantleapsomatichypermutationofasingleaminoacidleadstoantilaautoreactivity AT lilianarloureiro asmallstepagiantleapsomatichypermutationofasingleaminoacidleadstoantilaautoreactivity AT alexandrakegler asmallstepagiantleapsomatichypermutationofasingleaminoacidleadstoantilaautoreactivity AT edinsonpuentescala asmallstepagiantleapsomatichypermutationofasingleaminoacidleadstoantilaautoreactivity AT javierandressoto asmallstepagiantleapsomatichypermutationofasingleaminoacidleadstoantilaautoreactivity AT bijitkurien asmallstepagiantleapsomatichypermutationofasingleaminoacidleadstoantilaautoreactivity AT anjafeldmann asmallstepagiantleapsomatichypermutationofasingleaminoacidleadstoantilaautoreactivity AT nicoleberndt asmallstepagiantleapsomatichypermutationofasingleaminoacidleadstoantilaautoreactivity AT michaelpbachmann asmallstepagiantleapsomatichypermutationofasingleaminoacidleadstoantilaautoreactivity AT tabeabartsch smallstepagiantleapsomatichypermutationofasingleaminoacidleadstoantilaautoreactivity AT claudiaarndt smallstepagiantleapsomatichypermutationofasingleaminoacidleadstoantilaautoreactivity AT lilianarloureiro smallstepagiantleapsomatichypermutationofasingleaminoacidleadstoantilaautoreactivity AT alexandrakegler smallstepagiantleapsomatichypermutationofasingleaminoacidleadstoantilaautoreactivity AT edinsonpuentescala smallstepagiantleapsomatichypermutationofasingleaminoacidleadstoantilaautoreactivity AT javierandressoto smallstepagiantleapsomatichypermutationofasingleaminoacidleadstoantilaautoreactivity AT bijitkurien smallstepagiantleapsomatichypermutationofasingleaminoacidleadstoantilaautoreactivity AT anjafeldmann smallstepagiantleapsomatichypermutationofasingleaminoacidleadstoantilaautoreactivity AT nicoleberndt smallstepagiantleapsomatichypermutationofasingleaminoacidleadstoantilaautoreactivity AT michaelpbachmann smallstepagiantleapsomatichypermutationofasingleaminoacidleadstoantilaautoreactivity |
_version_ |
1718432072475869184 |